IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.536
NA - Nord America 6.157
AS - Asia 5.500
SA - Sud America 985
AF - Africa 77
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.978
RU - Federazione Russa 3.849
SG - Singapore 1.979
IE - Irlanda 1.730
CN - Cina 1.262
HK - Hong Kong 969
BR - Brasile 843
IT - Italia 805
UA - Ucraina 763
GB - Regno Unito 649
DE - Germania 600
FR - Francia 386
KR - Corea 386
VN - Vietnam 291
FI - Finlandia 228
SE - Svezia 210
IN - India 157
TR - Turchia 138
GR - Grecia 136
CA - Canada 131
JP - Giappone 126
AR - Argentina 46
AT - Austria 41
PL - Polonia 37
ID - Indonesia 36
BD - Bangladesh 33
MX - Messico 30
EC - Ecuador 26
BE - Belgio 25
PK - Pakistan 20
ZA - Sudafrica 20
IQ - Iraq 19
ES - Italia 16
NL - Olanda 16
CL - Cile 14
PE - Perù 14
SC - Seychelles 13
CZ - Repubblica Ceca 11
MA - Marocco 11
VE - Venezuela 11
CO - Colombia 9
PY - Paraguay 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AL - Albania 7
IL - Israele 7
KZ - Kazakistan 7
TN - Tunisia 7
AZ - Azerbaigian 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
EG - Egitto 6
IR - Iran 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
EU - Europa 5
KE - Kenya 5
UZ - Uzbekistan 5
JO - Giordania 4
NP - Nepal 4
PT - Portogallo 4
TH - Thailandia 4
AU - Australia 3
CG - Congo 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
RS - Serbia 3
BH - Bahrain 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
Totale 22.263
Salva come PNG Salva come JPEG
Città #
Dublin 1.722
Moscow 1.242
Jacksonville 1.174
Hong Kong 967
Santa Clara 950
Chandler 805
Singapore 754
Seoul 371
Princeton 244
Medford 216
New York 169
Hefei 168
Caserta 143
Ann Arbor 142
Roxbury 141
Beijing 140
Boardman 140
Bremen 133
San Mateo 125
Bengaluru 122
Naples 122
Ashburn 120
Munich 100
Elora 97
Wilmington 97
Ho Chi Minh City 79
Dallas 75
Woodbridge 74
São Paulo 68
The Dalles 66
Nanjing 65
Hanoi 55
Los Angeles 53
Dong Ket 52
Cambridge 51
Des Moines 50
Nuremberg 48
Napoli 46
Jinan 37
Mountain View 29
Rio de Janeiro 28
Kraków 26
Milan 26
Brussels 24
Tianjin 24
Belo Horizonte 23
Helsinki 23
Houston 22
Curitiba 19
Norwalk 19
Vienna 19
Aversa 18
Turku 18
Zhengzhou 18
Hangzhou 17
Rome 16
Shenyang 16
Changsha 15
Düsseldorf 15
Guangzhou 15
Jakarta 15
Tokyo 15
Aiello Del Sabato 14
Brasília 14
Nanchang 13
Shanghai 13
Auburn Hills 12
Ottawa 12
Guarulhos 11
Lanzhou 11
Porto Alegre 11
Taizhou 11
Brno 10
Ercolano 10
Lima 10
London 10
Salvador 10
San Francisco 10
Biên Hòa 9
Brooklyn 9
Falkenstein 9
Guayaquil 9
Istanbul 9
Jiaxing 9
Toronto 9
Trieste 9
Campinas 8
Chennai 8
Chicago 8
Haiphong 8
Hải Dương 8
Lappeenranta 8
Ningbo 8
Quito 8
Redwood City 8
Amsterdam 7
Atlanta 7
Da Nang 7
Fortaleza 7
Johannesburg 7
Totale 12.044
Salva come PNG Salva come JPEG
Nome #
ONCOLOGIA MEDICA 174
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 156
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 156
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 148
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 138
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 137
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 134
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 132
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 129
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 127
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 127
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 124
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 123
Clinical management of advanced gastric cancer: Role of new molecular drugs. 123
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 122
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 122
Predictive biomarkers along gastric cancer pathogenetic pathways 122
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 121
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 121
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 121
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 121
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 121
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 120
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 119
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 119
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 118
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 118
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 118
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 117
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 117
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy 116
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 115
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 115
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 114
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 114
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 114
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 113
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 113
Treatment of gastric cancer. 111
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 110
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 110
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 109
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 107
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 107
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 106
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 106
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 106
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 105
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 105
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 104
Farmacogenomica e cancro colorettale 104
Cardiotossicità da antracicline: attualità e prospettive 104
Adult Wilms' tumor: a case report 104
TRASTUZUMAB RESISTANCE IN BREAST CANCER 103
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 103
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 102
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 102
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 102
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 102
An intramedullary "flame" recognized as being an intramedullary spinal cord metastasis from esophageal cancer 101
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 100
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 99
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 99
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 98
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 98
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 98
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 98
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 97
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 97
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 97
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 97
Adjuvant chemotherapy of gastric cancer: which regimen? 96
Chemoradiotherapy as adjuvant treatment of gastric cancer 96
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 96
Targeting EGFR in Pancreatic Cancer Treatment. 96
Integrated therapy in localized gastric cancer: targeted and tailored approach. 95
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 95
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 95
Il linfoma primitivo della parotide: una localizzazione infrequente 95
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 94
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 94
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 93
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 93
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 93
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 93
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 92
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 92
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 92
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 92
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study 91
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 91
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 90
Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study. 90
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 90
Malignant transformation in non-recurrent peritoneal cystic mesothelioma Our experience and review of the literature 90
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 89
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 89
Neo-adjuvant and adjuvant chemotherapy of gastric cancer 89
Ventricular repolarization time indexes following anthracycline treatment 89
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 89
Totale 10.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 0 0 0 13 234 186 39 217 171 99
2021/20221.453 134 10 16 24 528 8 29 48 51 61 125 419
2022/20233.327 429 61 45 262 363 256 15 194 1.587 14 55 46
2023/20241.307 107 36 59 117 444 166 11 31 16 19 95 206
2024/20253.993 37 109 38 110 618 512 491 367 567 549 306 289
2025/20267.691 593 826 815 843 1.354 3.260 0 0 0 0 0 0
Totale 22.847